Literature DB >> 10797289

Genomic structure and mutation screening of the E2F4 gene in human tumors.

S Schwemmle1, G P Pfeifer.   

Abstract

E2F4, a member of the E2F family of transcription factors, is abundant in non-proliferating and differentiated cells where it plays an important role in the suppression of proliferation-associated genes. The E2F4 gene spans 6 kb and has 10 exons. It contains a serine (CAG) repeat tract in exon 7, which is unstable in gastrointestinal tumors. To further investigate a possible role of this gene in tumorigenesis we performed mutational analysis and expression studies in different tumors. Primary human tumor tissue of the stomach, colon, breast and lung (28), metastatic tumors of the colon (3) and small cell lung tumor cell lines (18) were screened for somatic mutations in the coding region of E2F4. No mutation was found. Microsatellite instability of the CAG repeat, however, was documented in primary stomach and colon tumors. Northern blot analysis revealed upregulated E2F4 transcript levels in tumor cell lines. Our data suggest that a direct involvement of E2F4 in tumorigenesis is unlikely, although increased E2F4 expression may be associated with human cancer. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10797289     DOI: 10.1002/(sici)1097-0215(20000601)86:5<672::aid-ijc11>3.0.co;2-x

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  19 in total

1.  EGFR promotes the proliferation of quail follicular granulosa cells through the MAPK/extracellular signal-regulated kinase (ERK) signaling pathway.

Authors:  Yan Wu; Hongwei Xiao; Jinsong Pi; Hao Zhang; Ailuan Pan; Yuejin Pu; Zhenhua Liang; Jie Shen; Jinping Du
Journal:  Cell Cycle       Date:  2019-08-29       Impact factor: 4.534

2.  E2F4 Program Is Predictive of Progression and Intravesical Immunotherapy Efficacy in Bladder Cancer.

Authors:  Chao Cheng; Frederick S Varn; Carmen J Marsit
Journal:  Mol Cancer Res       Date:  2015-06-01       Impact factor: 5.852

Review 3.  E2F transcription factors and digestive system malignancies: how much do we know?

Authors:  Athanasios Xanthoulis; Dina G Tiniakos
Journal:  World J Gastroenterol       Date:  2013-06-07       Impact factor: 5.742

Review 4.  Trinucleotide repeat expansions in human breast cancer-susceptibility genes: relevant targets for aspirin chemoprevention?

Authors:  M A Altinoz; N E Tunalı
Journal:  Clin Transl Oncol       Date:  2015-07-22       Impact factor: 3.405

Review 5.  Emerging roles of E2Fs in cancer: an exit from cell cycle control.

Authors:  Hui-Zi Chen; Shih-Yin Tsai; Gustavo Leone
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

Review 6.  Interplay between NRF1, E2F4 and MYC transcription factors regulating common target genes contributes to cancer development and progression.

Authors:  Kaumudi Bhawe; Deodutta Roy
Journal:  Cell Oncol (Dordr)       Date:  2018-07-25       Impact factor: 6.730

7.  RETRACTED: Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Breast Cancer

Authors:  Cheng-Cao Sun; Shu-Jun Li; Wei Hu; Jian Zhang; Qun Zhou; Cong Liu; Lin-Lin Li; Yi-Yan Songyang; Feng Zhang; Zhen-Long Chen; Guang Li; Zhuo-Yue Bi; Yong-Yi Bi; Feng-Yun Gong; Tao Bo; Zhan-Peng Yuan; Wei-Dong Hu; Bo-Tao Zhan; Qian Zhang; Qi-Qiang He; De-Jia Li
Journal:  Mol Ther       Date:  2019-04-06       Impact factor: 11.454

8.  Wide-ranging functions of E2F4 in transcriptional activation and repression revealed by genome-wide analysis.

Authors:  Bum-Kyu Lee; Akshay A Bhinge; Vishwanath R Iyer
Journal:  Nucleic Acids Res       Date:  2011-01-18       Impact factor: 16.971

9.  E2F4 regulatory program predicts patient survival prognosis in breast cancer.

Authors:  Sari S Khaleel; Erik H Andrews; Matthew Ung; James DiRenzo; Chao Cheng
Journal:  Breast Cancer Res       Date:  2014-12-02       Impact factor: 6.466

10.  Gain of function mutant p53 proteins cooperate with E2F4 to transcriptionally downregulate RAD17 and BRCA1 gene expression.

Authors:  Fabio Valenti; Federica Ganci; Giulia Fontemaggi; Andrea Sacconi; Sabrina Strano; Giovanni Blandino; Silvia Di Agostino
Journal:  Oncotarget       Date:  2015-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.